Media Coverage
Follow the latest media coverage of ITHS and the researchers we support.
Follow the latest media coverage of ITHS and the researchers we support.
October 22, 2022 Breast cancer vaccine safely generates anti-tumor immunity An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the journal –JAMA Oncology, lead author Dr. Mary “Nora” L. Disis, ITHS Principal Investigator and director of the Cancer Vaccine Institute.